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Cancer of the penis is a rare tumour in Europe and mainly aﬀects the elderly patient population. The aim of this paper was to
analyse and study the characteristics of this tumour, in our patient population. Materials and Methods. A retrospective study was
conducted on penile tumours diagnosed and treated in the Urology Department of the Hospital Universitario La Paz, Madrid, in
the last ten years. Results. A total of 34 patients were diagnosed and treated. The mean age at presentation was 71.27 years. The
meantimebetweensymptomsandtheﬁrstconsultationwas12.54monthswithamedianof6months.Themostcommonformof
presentation was balanoposthitis (32%) and the most common site in our series was the glans. Partial penectomy was performed
in 22 cases, total amputation in 8, and local excision in 3. Discussion. Carcinoma of the penis is a pathology which mostly aﬀects
elderly patients; in our series, the highest incidence was observed in patients in the group aged 75–84 years. The most common
histological type was epidermoid carcinoma in its various forms of presentation. We recorded a mortality of 23%. Conclusion.
Penile carcinoma is a rare pathology which aﬀects elderly persons and is diagnosed late.
Copyright © 2009 A. Rando Sous et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Penile cancer is a malignant tumour in which malignant cells
develop on the skin and/or the thin tissues of the penis.
Around 4000 cases are diagnosed each year, comprising
less than 0.5% of all cancers [1]. It is rare in Europe and
the United States, but not in developing countries or in
their immigrants to Europe and the USA [2]. The annual
incidence during the period 1993–1997 was estimated to
be less than 1/100000 men in the European population. As
always, some regions of Western Europe have an incidence
higher than 1/100000 (among these Malta, some regions of
Spain, Neuchatel in Switzerland, and Hauth-Rhin in France)
[3]. While in the United States, it represents 0.3% to 0.5%
of malignant tumours in men [4], it is estimated that for
2008, the United States will have 1250 new cases of penile
cancer and other genital cancers in men and an estimated
incidence of death of 290 cases [5]. The variation in the
world geographical incidence is evident and may be due
to diﬀerences in hygiene, social, and religious practices [6].
Penile cancer has a peak incidence in men aged over 70 years;
around 60% of cases present in men over 65 years [7].
The aim of our study was to present our series during the
last 10 years (1998–2008) and to analyse the results.
2.MaterialsandMethods
A retrospective study was carried out on a 10-year period
on a total of 34 patients treated for penile carcinoma in
the Hospital Universitario La Paz Urology Department,
between May 1998 and May 2008. The factors analysed were
age, history of phimosis and/or circumcision, time between
appearance of the lesion and the ﬁrst consultation, form of
presentation, presence of adenopathies, site of the lesion,
anatomical pathology results, type of surgery, postoperative
complications, lymphadenectomy, hospital stay, follow-up,
adjuvant therapy, and survival.
3. Results
A total of 34 patients were diagnosed and treated in a 10-year
period.Ourpatientswereagedbetween30and93years,with
a mean age of 71.27 years. The distribution according to age
is shown in Figure 1.2 Advances in Urology
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Figure 1: Distribution according to age.
Table 1: Macroscopic characteristics of the lesions.
Form of presentation Number of patients (%)
Balanoposthitis 11 (32.35)
Verrucous lesion 6 (17.64)
Indurated plaque 4 (11.76)
Ulcerated lesion 4 (11.76)
Phimosis 2 (5.88)
Stony mass 2 (5.88)
Not speciﬁed 2 (5.88)
Inguinal adenopathic mass 1 (2.94)
Urethrorrhagia 1 (2.94)
Scrotal abscess 1 (2.94)
Location
Prepuce 7
Glans 18
Balanopreputial sulcus 6
Body 1
Simultaneous glans-prepuce 2
Themeantimebetweentheappearanceofsymptomsand
the ﬁrst consultation was 12.54 months, with a median of 6
months. In 6 of our patients, the time between appearance
and its diagnosis was not shown in the medical record, as
they could not remember the date exactly. Ten of the patients
had phimosis at the time of diagnosis and seven had been
circumcised at some time in their lives. The macroscopic
characteristics of the lesions are shown in Table 1. The most
commonformofpresentationwasbalanoposthitis(32.35%),
followed by an ulcerous lesion (17.64%).
The most common site was in the glans. Table 2 shows
the surgical technique performed in relation to the tumour
stage. Surgery was decided against in one case only as there
was an inguinal mass which was considered inoperable. The
tumourwasanepidermoidcarcinomain94.17%ofthecases,
while only one case was verrucous carcinoma and another
was reported as diﬀuse intraepithelial carcinoma.
At the time of diagnosis, 17 patients had clinically pal-
pable inguinal adenopathies and 1 had a pelvic adenopathy
diagnosed by CT imaging. After antibiotic treatment, the
adenopathies became clinically undetectable in 6 patients;
in these cases it was considered that the adenopathies was
consequent the concomitant infection. Lymphadenectomy
was performed on 10 patients, pelvic and inguinal lym-
phadenectomy on 6 (hemipelvectomy was carried out in two
Table 2: Primary treatment according to the Stage of the primary
tumour.
Treatment Tx/T0 Tis Ta T1 T2 T3 T unknown
Local excision — 1 1 1
Penectomy
Partial — 1 1 14 6 — —
T o t a l — — — 224 —
None/Rejection — — — — — — —
Decided against — — — 1 — —
TOTAL 0 2 1 17 9 4 1
of these six), and inguinal bilateral only on 4. In the remain-
ing patients, lymph node management was by follow-up. In
those cases we made a modiﬁed inguinal lymphadenectomy,
and the surgical incision was horizontally inguinal.
The mean postoperative hospitalisation time was 2 days.
Only 3 patients in our series had adjuvant chemotherapy
administered due to evidence of metastatic disease during
follow-up and one had radiotherapy, due to the presence of
an inoperable inguinal tumour mass.
Our patients were followedup postoperatively for a mean
of 41.77 months and a median 31 (range from 0 to 190
months); postoperative monitoring was not carried out in
only 2 patients, as they did not attend the ﬁrst postsurgical
visit. During the follow-up, periodical physical examinations
(with biopsy in case of diagnostic uncertainty) and imaging
studies (CT, chest X-ray and/or ultrasound) were carried out
at three-month intervals for the ﬁrst two years and then
six-month intervals from then on; distant metastases were
observed in 5 patients. These patients were referred to the
Medical Oncology Department. We recorded a mortality of
23% in our series. All but one of those who died had positive
pelvic adenopathies, and 4 of the 8 deceased had received
adjuvant treatment, 3 with chemotherapy and one with
radiotherapy; the most widely used chemotherapy agents
werebleomycin,methotrexate,andcisplatin.Theuseofthese
drugs was decision of Oncology Department and we do not
ﬁnd any explication about that why they used one or another
medication on the clinical history. The start of adjuvant
therapy was 3 weeks after the surgery.
4. Discussion
Penile carcinoma is a neoplasm which mostly aﬀects elderly
patients; the usual age for this type of tumour is between
the 6th and 7th decade of life [8, 9]. In our series, the mean
age was 71.27 years, with a median of 71 years. The highest
incidence in the United States between 2001 and 2005 was
observed in the group aged 65–74 years, comprising 25.3%
o fa l lp e n i l ec a n c e r s[ 10]. In our series, the age range with
the highest incidence was between 75 and 84 years, with a
total of 11 patients (32.35%). The mean time between the
appearance of symptoms and the ﬁrst consultation was 12.54
months, with a median of 6 months, data similar to other
series.Advances in Urology 3
The characteristic form of presentation is an ulcerated
lesion, followed by inﬁltrating/deep lesion and papillary or
verrucous lesion [11]. In our series, the most common
form of presentation was balanoposthitis with 32.35% while
ulcerated lesion occupied fourth place with 11.76%. The
most common site in our series was the glans, followed by
the prepuce. In two cases, the lesion was even found in
both the prepuce and the glans at the time of diagnosis.
This is similar to the review by Diz Rodr` ıguez et al. [12]
but diﬀerent to the localisation reported in other series,
where the prepuce was found to be the most common site
[13].
The most common histopathological type was epider-
moidcarcinomainitsvariousformsofpresentation[8].This
ﬁnding remains similar in our series with 94.17% of cases.
The mean postoperative hospitalisation time was 2 days
(range from 0 days to 17 days) and a median of 1 day. This
canbe explained in our case,asin 33 of the 34 patients, treat-
ment was performed on the primary tumour only during
their ﬁrst hospitalisation and the lymphadenectomy on their
second stay. The patient who had the longest hospitalisation
time had a simultaneous hemipelvectomy and treatment of
the primary tumour, requiring admission to the intensive
care unit. In our department, the lymphadenectomy was
made in second time, with the intention to reduce the
morbility of the ﬁrst surgery. The mean time between the
surgery of the primary tumour and the lymphadenectomy
was a month.
Dissemination of penile cancer presents in stages; inﬁl-
tration of the inguinal lymph nodes is ﬁrst diagnosed,
followed by the iliac chain and ﬁnally distant metastases in
lessthan10%ofcases[14].Inourseries,weobserved11.76%
of distant metastases during follow-up of our patients. The
site of the metastases was lung, bone, liver, and inguinal
invasion. We recorded a cancer-speciﬁc mortality of 23.53%.
The 5-year survival was 82.35%, a survival similar to that
reported by the American Cancer Society, who states a
relative survival of 78% [15]. At the time of diagnosis of
the initial lesion, around 50% of patients have palpable
inguinal adenopathies; of these, only half will be tumours
as penile cancer is usually infected and causes inﬂammatory
adenopathies [16]. In our series, 50% had adenopathies
at the time of diagnosis, data similar to other published
series; however, it was due to an inﬂammatory process in
only 35% (6 patients). Among the 10 patients in whom
lymphadenectomy was performed, lymph node inﬁltration
was demonstrated in only 4 patients.
5. Conclusion
Penile carcinoma is pathology with low incidence in relation
to other tumours and is diagnosed late, probably due to
ignorance of the disease by our patients. It generally aﬀects
elderly men, and so the treatment given would not be
aggressive. The overtreatment many times carries on a lot
of side eﬀects. Therefore, it would be advisable to run
campaigns in the elderly male population recommending
early consultation in the case of any change in the penis;
however trivial it may seem.
References
[1] A. M. Mosconi, F. Roila, G. Gatta, and C. Theodorec, “Cancer
ofthepenis,”CriticalReviewsinOncology/Hematology,vol.53,
pp. 165–177, 2005.
[2] G. Micali, M. R. Nasca, D. Innocenzi, and R. A. Schwartz,
“Penile cancer,” Journal of the American Academy of Derma-
tology, vol. 54, no. 3, pp. 369–391, 2006.
[3] D. M. Parkin, S. L. Whelan, J. Ferlay, L. Teppo, and D.
B. Thomas, Cancer Incidence in Five Continents, vol. 8 of
IARC Scientiﬁc Publication no. 155, International Agency for
Research on Cancer, Lyon, France, 2002.
[4] J. S. Barnholtz-Sloan, J. L. Maldonado, J. Pow-sang, and
A. R. Guiliano, “Incidence trends in primary malignant
penile cancer,” Urologic Oncology: Seminars and Original
Investigations, vol. 25, no. 5, pp. 361–367, 2007.
[5] American Cancer Society, Cancer Facts and Figures 2008,
American Cancer Society, Atlanta, Ga, USA, 2008.
[6] S. Misra, A. Chaturvedi, and N. C. Misra, “Penile carcinoma: a
challenge for the developing world,” The Lancet Oncology, vol.
5, no. 4, pp. 240–247, 2004.
[7] ENCR (European Network of Cancer Registries), Eurocim
Version 4.0 European Incidence Database V2.2 (1999),E N C R ,
Lyon, France, 2001.
[8] G. Pizzocaro, L. Piva, G. Bandieramonte, and S. Tana, “Up-
to-date management of carcinoma of the penis,” European
Urology, vol. 32, no. 1, pp. 5–15, 1997.
[ 9 ]J .M .C ´ ozar, J. Navarro, J. de la Pe˜ na, et al., “Controversias
sobre la infadenectom´ ıa regional en el carcinoma de pene,”
Archivos Espanoles de Urologia, vol. 44, no. 8, pp. 951–955,
1991.
[10] SEER Cancer Statistics Review, 1975–2001, National Cancer
Institute, Bethesda, Md, USA.
[11] H. Villavicencio, J. Rubio-Briones, R. Regalado, G. Chechile,
F. Algaba, and J. Palou, “Grade, local stage and growth pattern
as prognostic factors in carcinoma of the penis,” European
Urology, vol. 32, no. 4, pp. 442–447, 1997.
[12] R. Diz Rodr´ ıguez, M. V´ ırseda Chamorro, and I. Arance
Gil, “Revisi´ on de los tumores epidermoides de pene,” Actas
Urologicas Espanolas, vol. 31, no. 1, pp. 7–10, 2007.
[13] R. Hunter-Mellado and P. Rodr´ ıguez, “Squamous cell carci-
noma of the penis,” Boletin de la Asociacion Medica de Puerto
Rico, vol. 82, no. 9, pp. 416–418, 1990.
[14] E. Solsona, “C´ ancer de pene,” Actas Urologicas Espanolas, vol.
26, no. 8, pp. 525–531, 2002.
[15] American Cancer Society, “Detailed guide: penile cancer,”
2008, http://www.cancer.org/docroot/CRI/content/CRI 2 4
3X How is penile cancer staged 35.asp?sitearea.
[16] M. Soto Delgado, F. Arredondo Mart´ ınez, and G. Pedrero
M´ arquez, “C´ ancer de pene. Una revisi´ on de 18 casos,” Actas
Urologicas Espanolas, vol. 27, no. 10, pp. 797–802, 2003.